| Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection J Zuo, AC Dowell, H Pearce, K Verma, HM Long, J Begum, F Aiano, ... Nature immunology 22 (5), 620-626, 2021 | 429 | 2021 |
| Host shutoff during productive Epstein–Barr virus infection is mediated by BGLF5 and may contribute to immune evasion M Rowe, B Glaunsinger, D van Leeuwen, J Zuo, D Sweetman, D Ganem, ... Proceedings of the National Academy of Sciences 104 (9), 3366-3371, 2007 | 287 | 2007 |
| The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation J Zuo, A Currin, BD Griffin, C Shannon-Lowe, WA Thomas, ME Ressing, ... PLoS pathogens 5 (1), e1000255, 2009 | 207 | 2009 |
| Cytomegalovirus infection leads to development of high frequencies of cytotoxic virus-specific CD4+ T cells targeted to vascular endothelium A Pachnio, M Ciaurriz, J Begum, N Lal, J Zuo, A Beggs, P Moss PLoS pathogens 12 (9), e1005832, 2016 | 196 | 2016 |
| Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection AC Dowell, MS Butler, E Jinks, G Tut, T Lancaster, P Sylla, J Begum, ... Nature immunology 23 (1), 40-49, 2022 | 190 | 2022 |
| Extended interval BNT162b2 vaccination enhances peak antibody generation H Parry, R Bruton, C Stephens, C Bentley, K Brown, G Amirthalingam, ... npj Vaccines 7 (1), 14, 2022 | 159 | 2022 |
| Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products ME Ressing, D Horst, BD Griffin, J Tellam, J Zuo, R Khanna, M Rowe, ... Seminars in cancer biology 18 (6), 397-408, 2008 | 159 | 2008 |
| Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia HM Parry, G McIlroy, R Bruton, M Ali, C Stephens, S Damery, A Otter, ... Blood Cancer J 11, 2021 | 126 | 2021 |
| The DNase of Gammaherpesviruses Impairs Recognition by Virus-Specific CD8+ T Cells through an Additional Host Shutoff Function J Zuo, W Thomas, D van Leeuwen, JM Middeldorp, EJHJ Wiertz, ... Journal of virology 82 (5), 2385-2393, 2008 | 122 | 2008 |
| Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years HM Parry, J Zuo, G Frumento, N Mirajkar, C Inman, E Edwards, M Griffiths, ... Immunity & Ageing 13, 1-10, 2016 | 118 | 2016 |
| The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules … J Zuo, LL Quinn, J Tamblyn, WA Thomas, R Feederle, HJ Delecluse, ... Journal of virology 85 (4), 1604-1614, 2011 | 100 | 2011 |
| Epstein-Barr Virus Evades CD4+ T Cell Responses in Lytic Cycle through BZLF1-mediated Downregulation of CD74 and the Cooperation of vBcl-2 J Zuo, WA Thomas, TA Haigh, L Fitzsimmons, HM Long, AD Hislop, ... PLoS pathogens 7 (12), e1002455, 2011 | 88 | 2011 |
| The missing link in Epstein-Barr virus immune evasion: the BDLF3 gene induces ubiquitination and downregulation of major histocompatibility complex class I (MHC-I) and MHC-II LL Quinn, LR Williams, C White, C Forrest, J Zuo, M Rowe Journal of virology 90 (1), 356-367, 2016 | 85 | 2016 |
| Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people H Parry, R Bruton, C Stephens, K Brown, G Amirthalingam, A Otter, ... Immunity & Ageing 18, 1-8, 2021 | 77 | 2021 |
| Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5–6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis H Parry, R Bruton, G Tut, M Ali, C Stephens, D Greenwood, S Faustini, ... The Lancet Healthy Longevity 2 (9), e554-e560, 2021 | 72* | 2021 |
| Immune responses to Epstein–Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity M Rowe, J Zuo Microbes and infection 12 (3), 173-181, 2010 | 71 | 2010 |
| The Transcription Factor Hobit Identifies Human Cytotoxic CD4+ T Cells AE Oja, FA Vieira Braga, EBM Remmerswaal, NAM Kragten, ... Frontiers in immunology 8, 325, 2017 | 69 | 2017 |
| NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma HM Parry, T Stevens, C Oldreive, B Zadran, T McSkeane, Z Rudzki, ... Oncotarget 7 (42), 68513, 2016 | 66 | 2016 |
| Cooperation between Epstein-Barr Virus Immune Evasion Proteins Spreads Protection from CD8+ T Cell Recognition across All Three Phases of the Lytic Cycle LL Quinn, J Zuo, RJM Abbott, C Shannon-Lowe, RJ Tierney, AD Hislop, ... PLoS pathogens 10 (8), e1004322, 2014 | 62 | 2014 |
| NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype F Marcon, J Zuo, H Pearce, S Nicol, S Margielewska-Davies, M Farhat, ... Oncoimmunology 9 (1), 1845424, 2020 | 55 | 2020 |
